256 related articles for article (PubMed ID: 19795398)
21. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
23. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
Huang M; Spitz MR; Gu J; Lee JJ; Lin J; Lippman SM; Wu X
Carcinogenesis; 2006 Oct; 27(10):2034-7. PubMed ID: 16638786
[TBL] [Abstract][Full Text] [Related]
25. CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
J Surg Oncol; 2011 Jun; 103(7):716-23. PubMed ID: 21308686
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
[TBL] [Abstract][Full Text] [Related]
27. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
29. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
[TBL] [Abstract][Full Text] [Related]
30. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
Naidu R; Yip CH; Taib NA
Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
[TBL] [Abstract][Full Text] [Related]
32. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
33. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.
Jin MJ; Chen K; Song L; Fan CH; Chen Q; Zhu YM; Ma XY; Yao KY
Cancer Genet Cytogenet; 2005 Nov; 163(1):38-43. PubMed ID: 16271954
[TBL] [Abstract][Full Text] [Related]
34. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
[TBL] [Abstract][Full Text] [Related]
35. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
[TBL] [Abstract][Full Text] [Related]
36. Death receptor 4 variants and colorectal cancer risk.
Frank B; Shanmugam KS; Beckmann L; Hemminki K; Brenner H; Hoffmeister M; Chang-Claude J; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):2002-5. PubMed ID: 17035413
[TBL] [Abstract][Full Text] [Related]
37. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
38. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
39. [Association between genetic polymorphisms in folate metabolic enzyme genes and colorectal cancer: a nested case-control study].
Chen K; Song L; Jin MJ; Fan CH; Jiang QT; Yu WP
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):429-32. PubMed ID: 17152488
[TBL] [Abstract][Full Text] [Related]
40. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]